← Leaderboards
Shruti Gupta
Brigham And Women'S Hospital
$1,120,717
Attributed
$1,120,717
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $332.2K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,120,717 · 3
By mechanism
K23$809,641 · 1
F32$167,108 · 1
R03$143,968 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Guo-Ping Shi$19,551,120
- Glenn T Furuta$8,443,753
- Yiqing Song$4,333,140
- Shiladitya Sengupta$10,066,982
- Leonard F.m Scinto$14,619
Others in their field
Other Emerging Leaders on “Design”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- John E West · University Of Texas At Austin$113,883,001
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
DesignSerumHigh RiskMortalityAdultObservational StudyRecruitAreaBloodTubular FormationEpidemiologyProspectivePharmaceutical PreparationsCreatinineIncidencePrimary OutcomeAnimal ModelCisplatinClinical TrialsMorbidity - Disease RateInjuryBiological MarkersBiobankFuture
Grant awards (8)
Novel Pathways and Therapeutic Targets for Cisplatin-Associated Acute Kidney Injury$188,266
K23 · FY2025 · DK · contact PI
Early Detection and Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA)$143,968
R03 · FY2025 · DK · contact PI
Novel Pathways and Therapeutic Targets for Cisplatin-Associated Acute Kidney Injury$189,269
K23 · FY2024 · DK · contact PI
Novel Pathways and Therapeutic Targets for Cisplatin-Associated Acute Kidney Injury$189,053
K23 · FY2023 · DK · contact PI
Novel Pathways and Therapeutic Targets for Cisplatin-Associated Acute Kidney Injury$54,000
K23 · FY2023 · DK · contact PI
Novel Pathways and Therapeutic Targets for Cisplatin-Associated Acute Kidney Injury$189,053
K23 · FY2022 · DK · contact PI
Chronic kidney disease as a risk factor for incident hearing loss$85,950
F32 · FY2019 · DC · contact PI
Chronic kidney disease as a risk factor for incident hearing loss$81,158
F32 · FY2018 · DC · contact PI